Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Hydrocortisone
Ovelle Limited
D07AA; D07AA02
Hydrocortisone
1 percent weight/weight
Cream
Product not subject to medical prescription
Corticosteroids, weak (group I); hydrocortisone
Marketed
1998-03-20
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT HYDROCORTISONE 1% W/W CREAM Hydrocortisone 1% w/w READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.See section 4. - You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET 1. What Hydrocortisone 1% w/w Cream is and what it is used for 2. What you need to know before you use Hydrocortisone 1% w/w Cream 3. How to use Hydrocortisone 1% w/w Cream 4. Possible side effects 5. How to store Hydrocortisone 1% w/w Cream 6. Contents of the pack and other information 1. WHAT HYDROCORTISONE 1% W/W CREAM IS AND WHAT IT IS USED FOR The name of your treatment is Hydrocortisone 1% w/w Cream. It is a smooth white aqueous cream. Hydrocortisone 1% w/w Cream contains hydrocortisone 1% w/w as the active ingredient. Hydrocortisone 1% w/w Cream is one group of medicines called corticosteroids. It works by lowering the production of substances that cause inflammation. It is used to relieve the itching, redness, swelling, dryness, inflammation and discomfort of various skin conditions (contact dermatitis, irritant dermatitis, insect bite reactions and mild to moderate eczema). 2. WHAT YOU NEED TO KNOW BEFORE YOU USE HYDROCORTISONE 1% W/W CREAM _ _ DO NOT USE HYDROCORTISONE 1% W/W CREAM - -On the eyes or face, the ano-genital region or the broken or infected skin including cold sores, acne and athletes foot. - - In the presence of untreated infections of bacterial, viral, tuberculosis or fungal origin. - - In the presence of acne, rosacea or on dermatitis affecting the area around the mouth or nose. - - If you are allercic to hydr Soma hati kamili
Health Products Regulatory Authority 20 January 2023 CRN00D6H2 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Hydrocortisone 1 % w/w Cream 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Hydrocortisone 1 % w/w Cream contains Hydrocortisone 1% w/w. Excipient(s) with known effect Contains 0.1% w/w chlorocresol and 7.2% w/w cetostearyl alcohol. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Cream Smooth white aqueous cream. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hydrocortisone 1 % w/w Cream is recommended for the topical treatment of contact dermatitis, irritant dermatitis, insect bite reactions, mild to moderate eczema. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Hydrocortisone 1 % w/w Cream is applied topically. _Recommended dosage schedules:_ _Adults: _Use sparingly over a small area once or twice daily for a maximum period of one week. _Children: _Hydrocortisone 1 % w/w Cream is not recommended for use in children under 12 years without medical supervision. 4.3 CONTRAINDICATIONS Hydrocortisone 1 % w/w Cream is contraindicated for use on the eyes or face, the ano-genital area or on broken or infected skin including cold sores, acne and athletes' foot. Use in the presence of untreated infections of bacterial, viral, tuberculous or fungal origin. Use in acne vulgaris, acne rosacea or in perioral dermatoses. Hypersensitivity to the preparation. Use in plaque psoriasis. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Hydrocortisone 1 % w/w Cream is not recommended for use in children under 12 years, except under medical supervision. Prolonged use of uninterrupted occlusion or use with extensive occlusive dressings may suppress adrenocortical function. Continuous application without interruption will result in local atrophy of the skin, striae, and superficial vascular dilatation, particularly on the face. Long term continuous or inappropriate use of topical steroids can result in the development of rebound flares after stopping treatment (topical steroid withdr Soma hati kamili